Antibacterial Properties of Phytochemicals Isolated from Leaves of Alstonia boonei and Aerial Parts of Ipomoea cairica

Abstract

Objective

The leaves of Alstonia boonei and aerial parts of Ipomoea cairica are used for treatment of microbial infections among other ailments in African traditional medicine. The aim of this study was to investigate the antimicrobial phytochemicals in A. boonei leaves and Ipomoea cairica aerial parts to validate their traditional use in Ugandan herbal medicine.

Methods

The plant materials were separately extracted using a dichloromethane/methanol (1:1) solvent system and subjected to repeated chromatographic separation to isolate pure compounds. The chemical structures of the isolated compounds were determined through ¹H NMR, ¹³C NMR and 2D NMR (COSY, HSQC and HMBC). The antibacterial activity of the extracts and pure compounds were assessed using the agar well diffusion method.

Results

Chromatographic fractionation of the extracts yielded trans-fagaramide and a pentacyclic lupane-type triterpenoid, lupeol, from A. boonei, and friedelin from I. cairica. Trans-fagaramide was identified for the first time in the Alstonia genus while friedelin was identified for the first time in I. cairica. The isolated compounds demonstrated antibacterial activity, with trans-fagaramide showing a minimum inhibitory concentration (MIC) of 125 μg/mL against Pseudomonas aeruginosa and 250 μg/mL against Staphylococcus aureus, Salmonella typhi and Escherichia coli. Friedelin exhibited a MIC of 125 μg/mL against Escherichia coli and 250 μg/mL against Pseudomonas aeruginosa, Staphylococcus aureus and Salmonella typhi.

Conclusion

The antibacterial activities observed in this study support the traditional use of A. boonei and I. cairica by indigenous communities in Uganda for treating microbial infections.

Keywords

antibacterial friedelin lupeol trans-fagaramide

Introduction

Despite the significant progress made in the treatment of emerging and known microbial infections, pathogenic diseases have remained among the major causes of morbidity and mortality. For example, it accounted for at least 13.5% (13.7 million) deaths reported globally in 2019.¹ The underlying causes of this disease burden is partly due to continuous development of resistance to the current-use conventional drugs. In addition, infringement on the pristine environment and domestication of wildlife have spiraled human–animal interactions, opening new windows for transmission of zoonoses and unique pathogens to humans.² A case in point is the COVID-19 pandemic that has, by and large, been considered the worst infectious disease witnessed in the twenty-first century.³

The burden of pathogenic diseases is disproportionately high in developing countries and this has prompted communities to embrace traditional medicine for healthcare.^4–6 In Africa, traditional medicine has long been a cornerstone of healthcare for communities where plant-based remedies are frequently used to treat a wide range of ailments, including microbial infections. The preference for medicinal plants over conventional medicine is largely driven by cultural perspicacity and beliefs, both of which varies across countries.^7–9 In East Africa, the use of herbs for primary healthcare has been widely documented.¹⁰ In Uganda, the use of herbal remedies is an integral part of the healthcare systems.^11,12 This study focused on two species (Alstonia boonei and Ipomoea cairica) used in the treatment of microbial infections in Uganda.

Alstonia boonei De Wild. (Apocynaceae) is a deciduous tree locally known as mubajangalabi (Luganda), nsiwa (Lusoga) and mujwa (Runyoro) in Uganda.¹³ It is used in the treatment of malaria and microbial infections.¹⁴ In other parts of Africa (where it is called pattern wood or stoolwood), this species is used in the treatment of (cerebral) malaria, snake envenomation, insomnia, arrow poison, hypertension, microbial infections, cancer, painful micturition, diarrhoea and inflammations.^15–17 In some African countries, A. boonei is a sacred tree that is cherished and therefore not usually eaten.¹⁸ The stem bark, leaves and roots of this species has antiplasmodial,^19–23 analgesic, anti-inflammatory,²⁴ antipyretic,²⁵ antimicrobial,²⁶ antidiarrheal,²⁷ anticancer,²⁸ antioxidant, anti-ulcer,²⁹ hepatoprotective and neuroprotective activities.^16,30 Plants are known to produce a vast array of secondary metabolites that serve protective roles against pathogens and environmental stressors. These bioactive compounds, including alkaloids, flavonoids, terpenoids, and phenolics, are often responsible for the antimicrobial properties observed in medicinal plants. Although the antimicrobial and antidiarrheal activities of A. boonei has been studied,^26,27 complete characterization of the compounds associated with its bioactivities is far from accomplished. Marini-Bettolo et al³¹ first isolated boonein, a monoterpenoid δ-lactone from the bark of A. boonei. Omitola²⁷ reported the presence of boonein and β-amyrin in the leaf extracts while Olanlokun et al found an antimalarial compound: tetrahydro-4-((E)-7-hydroxy-10-methoxy-6,14-dimethyl-15-m-tolylpentadec-13-enyl) pyran-2-one in the stem bark extract of this species.³² Kiganda³³ found that A. boonei stem and root barks had cycloeucalenol, lupeol, phenanthridine-6(5H)-one, lupeol acetate, stigmasterol, lichexanthone, β-sitosterol and echitamine. Acylated anthocyanins and flavonoids have also been characterized in this species.³⁴ Recently, methanolic stem bark extract of A. boonei was found to contain loganic acid, along with two new compounds: secoxyloganin and sweroside.³⁵

On the other hand, Ipomoea cairica (L.) Sweet is an invasive vine in family Convolvulaceae.³⁶ It is a twining perennial herb that persists for more than two years. With showy white to lavender-colored flowers (hence the name five-fingered morning glory), Ipomoea cairica (I. cairica hereafter) is native to tropical Africa and Asia.³⁴ In Uganda, it is known as akarandarugo, and its leaves and stems are used in the treatment of microbial infections,³⁷ cervical cancer, uterine diseases and colic pain.³⁸ In Kenya, powdered leaves and roots are applied topically for breast, cervical and skin cancer treatment.³⁹ In Brazilian traditional medicine, I. cairica is used in the treatment of rheumatism and inflammations.⁴⁰ To date, the antinociceptive,⁴⁰ larvicidal,^41–43 anticancer⁴⁴ and antidiabetic⁴⁵ activities of I. cairica extracts and some coumarins (scopoletin, umbelliferone), lignans (arctigenin, matairesinol, (+)-pinoresinol and trachelogenin) and acylated anthocyanins in it has been reported.³⁴ This species is also rich in pentasaccharide resin glycosides (cairicosides A-F), mainly in its aerial parts.^44–46

Research into the chemical composition and biological activities of compounds from A. boonei and I. cairica are still inadequate to understand the compounds associated with their uses claimed in traditional medicine. Such studies are crucial for understanding the pharmacological basis of their traditional uses and for potentially developing novel plant-derived antimicrobial agents that could be used to counter the increasing antimicrobial resistance crisis.²⁶ In continuity of our search for bioactive natural products with antimicrobial activities in Uganda,^47–50 the objective of the present study was to isolate and characterize the phytochemicals in A. boonei leaves and I. cairica aerial parts and to assess their antibacterial activities. By identifying and testing these compounds against common bacterial pathogens, this study aimed to provide scientific validation for the traditional use of these plants in treating microbial infections and to contribute to the growing body of knowledge on plant-based antibacterial agents.

Materials and Methods

Plant Organs and Extraction of Phytochemicals

Leaves of A. boonei and aerial parts of I. cairica were sampled from Nakawuka village, Wakiso District and Nakawa Division, Kampala District, Uganda, respectively. Both samples were identified and authenticated by a taxonomist at Makerere University Herbarium where voucher samples (IG005 and IG006) were deposited. The samples were dried under shade for 3 weeks.

The pulverized samples (1 kg of A. boonei leaf powder and 620 g of I. cairica aerial parts) were exhaustively extracted by cold percolation at room temperature using a mixture of dichloromethane and methanol (DCM/MeOH, 1:1, v/v) for 48 h, with occasional stirring. The choice of this solvent system is because DCM and MeOH have different polarities and their mixture is able to solubilize both non-polar and polar compounds. Thus, we targeted this solvent system because it would extract a wide variety of phytochemicals, including alkaloids, flavonoids, terpenoids, and steroids. The extracts obtained were then filtered, and the filtrates were concentrated by rotary evaporation at 40 °C. The crude extracts obtained were stored at 4 °C until further analysis.

Isolation and Spectroscopic Analysis of Compounds

Chromatographic separation was done using 15 g and 100% of n-hexane (to remove fats and oils for two days) and then serially with solvent systems of increasing polarity at 5% increments upto 100% ethyl acetate and methanol. The fractions obtained were concentrated on a rotary evaporator and spotted on analytical TLC plates (TLC sheets ALUGRAM^® Xtra SIL G/UV254, Macherey-Nagel GmbH & Co. KG, Germany). Fractions with similar TLC profiles were combined.⁵¹ For each eluent system, two litre solvent volumes were used and 250 ml fractions were collected. The fractions were concentrated and repeatedly fractionated using DCM/MeOH (1:1) as the eluent system to obtain the pure compounds.⁵²

The structure of each compound isolated was established from NMR data obtained on a Bruker AV-500 spectrometer (MC-Murry) ie, 1D (¹H and ¹³C) and 2D (H-H COSY, HSQC and HMBC) spectra of the samples dissolved in deuterated chloroform. The spectra in FID format were processed using MestReNova (version 8.1.1). NMR results with residual chloroform peaks were used as the references. The results were compared with published spectroscopic data.

Antibacterial Activity Assessment

The antibacterial assay followed the agar well diffusion method. Briefly, the bacterial strains were American Type Culture Collection (ATCC) of Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), Salmonella typhi (S. typhi) and Pseudomonas aeruginosa (P. aeruginosa). The choice of the bacteria was informed by the bacterial diseases for which the plants are traditionally used to treat, the WHO priority list of bacteria as well as the availability of the test strains.⁴⁹ The bacteria were all obtained from Department of Biological Sciences, Kyambogo University, Kampala, Uganda where the assays were performed.

The bacterial cultures were maintained on nutrient agar slants for a day after incubation at 37 °C. They were stored at 4 °C as stock cultures for antibacterial assays. Using sterile 6-mm glass cork borers, wells were carefully made on the agar plates without distorting the media. Tetracycline (0.5 mg/mL) and dimethyl sulfoxide (DMSO) were used as the positive and negative controls, respectively. In the bioassays, exactly 50 μL of the prepared extracts (0.5 mg/mL in DMSO) and the controls were pipetted into the wells, left on the bench for 60 min and thereafter incubated at 37 °C for 24 h. The antibacterial activities were determined by measuring the inhibition zone diameter (ZOI).

Utilizing the broth-dilution method, bacteria with the highest sensitivity to the extracts and isolated compounds (1 and 3) were used for minimum inhibitory concentration (MIC).⁴⁹ Compound 2 was obtained in very little quantities, and was therefore, not tested. The test sample was serially diluted in sterile Mueller Hinton broth by a factor of 2 to 4 in a volume of 300 mg/mL for crude extract and 100 μg/mL for compounds 1 and 3. In sequence of increasing dilution, the test organism was aseptically added to each of the tubes containing the sample. The dilutions were in series of 500, 250, 125, 62.5, 31.25, 15.265, 7.8125, 3.90625 mg/mL for the extracts and the corresponding values in μg/mL for the compounds. The tubes were then incubated for 24 h at 37 °C and turbidity was used to look for growths.

Results

Isolated Compounds from A. boonei Leaf Extracts

Two compounds: trans-fagaramide (1) and lupeol (2) were isolated from extract of A. boonei leaves (Figure 1). Compound 1 was obtained as a white powder (29.1 mg), soluble in DCM and its NMR spectral data and spectra are given in Table S1 and Figures S1-S7. The ¹³C NMR showed 13 peaks, including that of an amide carbonyl (δ 166.3). The HSQC revealed the presence of a methylenedioxy group with a cross-peak coordinate at δ_H 5.69 (2H), (δ_C 101.4). From ¹H NMR and ¹H-¹H COSY, the presence of a trans-double bond was deduced (δ_H 7.54 (1H, d, J = 15.6 Hz); δ_H 6.32 (1H, d, J = 15.6 Hz)). Furthermore, the HSQC spectra revealed a cross peak at δ_H 7.54, δ_C 140.1, implying that the double bond was adjacent to an electron-withdrawing atom. From ¹H NMR and ¹H-¹H COSY spectra, it was also deduced that 3 aromatic protons were present (δ_H 6.98 (brs, 1H); δ_H 6.94 (d, 1H, J = 8.0) and δ_H 6.76 (dd, 1H, J = 8.0, 1.7 Hz), two of which were ortho to each other. The ¹H NMR and ¹H-¹H COSY spectra also revealed the presence of an isobutyl moiety [δ_H 3.21 (2 Hz, multiplet H–11, H–13/14); δ_H 1.85 (1H, a septet of doublets, J = 6.5. 1.7 Hz) and δ_H 0.95 (6H, d d, J = 6.7, 1.7 Hz). In addition, the HMBC indicated a correlation between the methylene proton at δ_H 3.21 H–11a and a carbonyl carbon at δ_C 166.3 (C–9) thus suggesting a connection with the amide group. The linkage between the trans-double bond with aromatic ring system at position 4 was deduced from the HMBC interaction between a proton at δ7.54 (H–7) with aromatic carbons at δc 106.4 (C–3) and δc 123.7 (C–5).

Figure 1.

Structure of bioactive compounds characterized in dichloromethane/methanol extracts of A. boonei leaves (1 and 2) and I. cairica aerial parts (3). In the structure of trans-fagaramide (1), the secondary amide linker pharmacophore believed to contribute to its antimicrobial activity is highlighted.

Compound 2, obtained as a brown solid, was eluted with ethyl acetate/hexane (3:7) from the column. The ¹H NMR spectrum of 1 (Table S2; Figure S8) revealed the presence of 7 methyl protons at δ 0.76, 0.79, 0.83, 0.94, 0.97, 1.03 and 1.68 (integrated for 3H-each). A sextet of one proton at δ 2.38 ascribable to H-19, is characteristic of lupeol.^53,54 The H-3 proton showed a multiplet at δ 3.2 while a pair of broad singlets at δ 4.57 and δ 4.69 (1H, each) was indicative of olefinic protons at H-29 a & b.^55,56 The structure was further substantiated by the ¹³C NMR experiments which showed seven methyl groups at δ 28.1 (C-23), δ 18.1 (C-28), δ 16.2 (C-25), δ 16.0 (C-26), δ 15.4 (C- 24), δ 14.6 (C-27) and δ 19.4 (C-30); there is an exomethylene group at δ 109.5 (C-29) and δ 150.6 (C-20). A signal at δ_C 79.1 was attributed to C-3 with a hydroxyl group attached to it (Table S2; Figure S9).

The confirmation of the structure was accomplished through 2D NMR experiments (COSY, HSQC and HMBC) (Figures S10–S12). The H-H COSY spectrum of the compound exhibited some cross peaks such as between δ 2.38, H-19 and one methylene proton δ1.33, H-21 and between methine proton δ3.18, H-3 and methylene s (δ 1.57, H-2). In the HMBC spectrum, the methine proton at δ3.18 (H-3) showed cross peaks with a methyl carbon δ28.1, C-23) by J₂ correlation and a methyl carbon δ 18.4, C-6) by J₃ correlation. The methine proton at δ 2.38 (H-19) showed cross peaks with two methylene carbon δ29.9 (C-21) and δ109.5 (C-29), a methine carbon 48.4 (C-18), a methyl carbon δ 19.4 (C-30)] and a quaternary carbon δ 150.6 (C-20). The pair of broad singlets of proton at δ 4.57 and 4.69 showed cross peaks with a methylene carbon δ 48.1(C-19), δ150.6 (C-20) and δ 109.5 (C-29)] by J₃ correlation.

Isolated Compound from I. cairica Aerial Part Extract

One compound (3) weighing 58.4 mg was isolated from the extract of I. cairica aerial parts on re-chromatography (Figure 1). It was obtained as a white amorphous solid with 1% ethyl acetate in n-hexane. The ¹³C NMR displayed 30 significant peaks implying the compound had 30 non-equivalent carbon atoms (Table S3; Figure S13). The spectrum had the following peaks: carbon at δ 167.7 (C-1) assigned to carbonyl carbon, carbons at δ 59.6 (C-2), δ 58.4 (C-3), δ 53.2 (C-4) and δ 42.9 (C-5) assigned to CH, carbons at δ 42.3 (C-6), δ 39.8 (C-9), δ 38.4 (C-11), δ 37.6 (C-12), δ 22.7 (C-22) and δ 22.4 (C-23) assigned to quaternary carbons, carbons at δ 41.7 (C-7), δ 41.4 (C-8), δ 39.1 (C-10), δ37.3 (C-13), δ 35.8 (C-14), δ 35.5 (C-15), δ 32.2 (C-17), δ 31.9 (C-18), δ 22.9 (C-21), δ 22.3 (C-24) and δ 18.1 (C-27) assigned to CH₂ carbons, carbons at δ 35.2 (C-16), δ 29.8 (C-19), δ 23.7 (C-20), δ 20.4 (C-25), δ 18.8 (C-26), δ 14.8 (C-28), δ 14.3 (C-29) and δ 6.9 (C-30) assigned to CH₃ carbons.

The ¹H NMR spectrum of 3 (Figure S14) displayed the following peaks; multiplet at δ 1.53 (3H, H-2, H-5, H^a-10), δ 2.27 (1H, H-3), δ 1.40 (1H, H-4), δ 2.38 (1H, H^a-7), δ 2.31(1H, H^b-7), δ 1.28(3H, H^a-8, H^a-14, H^a-17), δ 1.76 (1H, H^b-8), δ 0.93 (1H, H^b-10), δ 1.38 (1H, H^a-13), δ 1.57 (1H, H^b-13), δ 1.46 (1H, H^b-14), δ 1.39 (1H, H^a-15), δ 1.20 (1H, H^b-15), δ 1.43 (1H, H^b-17), δ 1.31 (1H, H^a-18), δ 1.50 (1H, H^b-18,), δ 1.38 (2H, H-21), δ 1.95 (1H, H^a-24), δ 1.68 (1H, H^b-24), δ 1.46 (1H, H^a-27) and δ 1.36 (1H, H^b-27), singlets at δ 1.00 (3H, H-25), δ 1.18 (3H, H-19), δ 0.99 (3H, H-16), δ 1.05 (3H, H-26), δ 0.72 (3H,H-28) and δ 0.91 (3H, H-29) and a doublet at δ 0.88 (3H, J = 6.8, H-30). Protons attached to particular carbons was established using HSQC spectrum (Figure S15) which revealed the that carbons; C-1, C-6, C-9, C-11, C-12, C-22 and C-23 had no protons, C-2 was bonded to H at δ 1.53, C-3 bonded to H at δ 2.27, C-4 bonded to H at δ 1.40, C-5 bonded to H at δ 1.53, C-7 bonded to H at δ 2.38 and 2.31, C-8 bonded to H at δ 1.28 and 1.76, C-10 bonded to H at δ 1.53 and 0.93, C-13 bonded to H at δ 1.38 and 1.57, C-14 bonded to H at δ 1.28 and 1.46, C-15 bonded to H at δ 1.39 and 1.20, C-16 bonded to H at δ 0.99, C-17 bonded to H at δ 1.28 and 1.43, C-18 bonded to H at δ 1.31 and 1.50, C-19 bonded to H at δ 1.18, C-20 bonded to H at δ 1.50, C-21 bonded to H at δ 1.38, C-24 bonded to H at δ 1.95 and 1.68, C-25 bonded to H at δ 1.00, C-26 bonded to H at δ 1.05, C-27 bonded to H at δ 1.46 and 1.36, C-28 bonded to H at δ 0.72, C-29 bonded to H at δ 0.91 and C-30 bonded to H at δ 0.88. Further connectivity was established using H-H COSY, HSQC and HMBC spectra (Figures S15-S17). H-H COSY revealed the coupling of the following protons; H-2 and H-24, H-3 and H-30, H-4 and H-27, H-7 and H-24, H-8 and H-27, H-10 and H-17, H-13 and H-18, H-14 and H-21, H-15 and H-5. This implied that C-24 is bonded to C-2 and C-7, C-3 is bonded to C-30, C-27 is bonded to C- 8 and C-4, C-10 is bonded to C-17, C-13 is bonded to C- 18, C-14 is bonded to C-21, C-5 is bonded to C-15. From HMBC; C-1 coupled with H-7 and H-3, C-2 coupled with H-3, H-4, H-7, H-8 and H-24, C-3 coupled with H-7, H-8 and H-29, C-4 coupled with H-2, H-8, H-14, H-25 and H-28, C-5 coupled with H-10, H-13, H-19 and H-26, C-6 coupled with H-2, H-3, H-24, H-27 and H-29, C-7 coupled with H-2 and H-3, C-8 coupled with H-4 and H-29, C-9 coupled with H-4, H-5, H-21, H-25, and H-26, C-10 coupled with H-5 and H-19, C-11 coupled with H-4,H-13, H-18, H-25 and H-26, C-12 coupled with H-2, H-4, H-14, H-21 and H-28, C-13 coupled with H-5, H-10 and H-19, C-14 coupled with H-2, H-4 and H-28, C-15 coupled with H-16, H-17 and H-20, C-16 coupled with H-15, H-17 and H-20, C-17 coupled with H-15, H-16 and H-20, C-18 coupled with H-4 and H-25, C-19 coupled with H-5, H-10 and H-13, C-20 coupled with H-15, H-16 and H-17, C-21 coupled with H-5 and H-26, C-22 coupled with H-5, H-10, H-13, H-17, H-18 and H-19, C-23 coupled with H-5, H-10, H-15, H-16, H-17 and H-20, C-24 coupled with H-7, C-25 coupled with H-4 and H-18, C-26 coupled with H-5 and H-21, C-27 coupled with H-4, C-28 coupled with H-14, H-2, H-4 and H-24, C-29 coupled with H-2, H-3 and H-8 and C-30 coupled with H-3 (Table S3). These NMR data indicated that compound 3 has 50 protons, giving its molecular formula as C₃₀H₅₀O.

Antibacterial Activity of the Crude Extracts and Isolated Compounds

The antimicrobial activity of crude extracts and isolated compounds (1 and 3) were investigated. In the screening assay, extracts of A. boonei leaves had mean ZOI of 9.0 ± 1.0, 20.0 ± 2.5 and 10.0 ± 0.7 mm against P. aeruginosa, E. coli and S. aureus. The extract had no inhibitory activity against S. typhi. Similarly, DMSO had no inhibitory effects against the tested bacterial strains. Tetracycline (positive control) had average inhibition diameters of 50.0 ± 0.0, 50.0 ± 0.2, 50.0 ± 0.0 and 60.0 ± 0.9 mm, respectively. Extracts of aerial parts of I. cairica had mean ZOI of 23.0 ± 1.0, 26.0 ± 2.0, 13.0 ± 0.5 and 20.0 ± 0.8 mm against P. aeruginosa, E. coli, S. aureus and S. typhi, respectively.

Upon testing for MIC, compounds 1 and 3 exhibited antibacterial activity with the most susceptible bacteria being P. aeruginosa and E. coli. The MIC were 125 μg/mL against P. aeruginosa and 250 μg/mL against S. aureus, S. typhi and E. coli for 1, 125 μg/mL against E. coli and 250 μg/mL against the other bacteria for 3 (Table 1).

Table 1.

Minimum Inhibitory Concentrations of the Extracts (mg/mL) and Compounds (μg/mL) from A. boonei and I. cairica.

Bacteria	Extracts		Isolated compounds
Bacteria	A. boonei	I. cairica	1	3
P. aeruginosa	125	250	125	250
S. typhi	250	125	250	250
E. coli	250	125	250	125
S. aureus	250	250	250	250

Discussion

Chromatographic fractionation of the extracts followed by detailed spectroscopic analysis in this study yielded trans-fagaramide (1) and a pentacyclic (lupane-type) triterpenoid–lupeol (2) from A. boonei, and friedelin (3) from I. cairica. Compound 1 was identified by complete analysis of its HMBC and comparison of its spectral data with published literature.^50,54,55 Finally, the partial structures were joined to give the final structure as (2E)-3-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)prop-2-enamide, a lignan also known as trans-fagaramide (Figure 1). This lignan has been previously reported in plants such as Zanthoxylum leprieurii,⁵⁰ Zanthoxylum zanthoxyloides⁵⁵ and Fagara heitzii.⁵⁶ It is the first time trans-fagaramide is being reported in this species and genus.

Similarly, the analysis and comparison of spectral data of 2 with preceding reports^48,50,57 led to its identification as lupeol, a well-known pentacyclic triterpenoid. The lupane series triterpenoid (2) and its ester (lupeol acetate) has been previously characterized with other functional triterpenoids (α-amyrin, β-amyrin, cycloeucalenol, friedelan-3-one and ursolic acid) from A. boonei stem and root barks.^28,33,58,59 It is also widely reported in species in genera such as Albizia,^48,60 Bryophyllum,⁶¹ Combretum⁶² and Zanthoxylum.⁵⁰ Through comparison of the spectral data of 3 with published literature,^63–65 it was deduced to be friedelin. In I. cairica, only pentasaccharide resin glycosides (cairicosides A-F), β-sitosterol 3-O-glycopyranoside and tracheloside have been previously isolated from the aerial parts,^44–46,66 and friedelin (3) is hereby identified for the first time in this species. Friedelin was initially isolated from the root extracts of Ipomoea species (I. batatas).⁶⁴ Nevertheless, it is a common pentacyclic triterpenoid found in several plants such as Azima tetracantha,⁶⁷ Diospyros glandulosa,⁶³ Maytenus forsskaoliana,⁶⁵ Polygonum bistorta,⁶⁸ and Quercus stenophylla.⁶⁹

The antibacterial activity of extracts and compounds 1 and 3 were investigated. Extracts of A. boonei leaves had inhibitory effects on the growth of P. aeruginosa, E. coli and S. aureus but no activity against S. typhi. The DCM/MeOH extracts obtained from aerial parts of I. cairica also inhibited the growth of P. aeruginosa, E. coli, S. aureus and S. typhi, respectively. These results suggested that these plant extracts elicit antibacterial effect against pathogenic bacteria, corroborating a previous report on A. boonei.²⁶ In addition, the inhibition zones recorded in this study for A. boonei leaf extracts were higher than 5-10 mm previously reported for the ethanolic and methanolic root extracts of this species from Ghana.²⁶ Organic (hexanic, chloroform and ethyl acetate) fractions of methanolic extract of A. boonei leaves were found inhibit a panel of pathogenic S. typhi, Shigella dysentriae, Enterococcus faecalis, E. coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, S. aureus, Proteus mirabilis with MIC ranging from 1.33 to 25.0 mg/mL.⁷⁰ A previous report on the antibacterial activity of methanolic extracts of I. cairica leaves and flowers found that they had inhibitory activity against E. coli (ZOI = 22 mm and 11 mm), Klebsiella pneumonia (ZOI = 11 mm and 10 mm), S. typhi (ZOI = 13 mm and 11 mm), Bacillus subtilis (ZOI = 10 mm and 15 mm), S. aureus (ZOI = 8 mm and 13 mm) which are lower than the inhibition diameters we found in the current study.⁷¹

Assessment of MIC of 1 and 3 suggested that they had antibacterial activity against the tested panel of bacteria. The MIC values span from 125 μg/mL to 250 μg/mL (Table 1). In comparison with previous studies, trans-fagaramide (1) has been previously demonstrated to have antimicrobial activity against Mycobacterium tuberculosis (H37Rv strain, MIC = 6 μg/mL and multidrug resistant strain, MIC = 12.2 μg/mL).⁵⁰ Trans-fagaramide is an amide alkaloid with various biological and chemical properties beyond its antimicrobial efficacy that could contribute to its overall therapeutic potential. Firstly, trans-fagaramide exhibit antioxidant properties which could protect tissues from oxidative stress and improve the host's defense mechanisms against microbial pathogens, thus enhancing its therapeutic efficacy against infections.⁵⁶ Secondly, it possesses a secondary amide linker in its structure (Figure 1). This linker pharmacophore is present in the structures of rifampicin, amikacin, capreomycin, isoniazid and pyrazinamide which are drugs used in the treatment for tuberculosis, a microbial infection.^50,72

Although lupeol (2) was not tested in this study, it has been isolated from plant extracts and shown to elicit antibacterial activity against Shigella dysentriae, E. coli, S. aureus, P. aeruginosa, S. typhi, Bacillus cereus, Shigella boydi, Enterobacter aerogenes, Listeria monocytogenes, Bacillus subtilis, Klebsiella pneumoniae, Staphylococcus lutea, and Vibrio mimicus.^73–76 In addition to this, lupeol possess anti-inflammatory and immunomodulatory effects which can improve the healing process during infections and reduce tissue damage caused by inflammatory responses.⁷⁷ Like trans-fagaramide, lupeol has significant antioxidant activity which can protect cells from oxidative damage that occurs during infections.⁷⁸ Further, lupeol promotes wound healing by enhancing the deposition of collagen and promoting the proliferation of keratinocytes and fibroblasts.⁷⁹ This is mediated through activation of PI3k/Akt and p38 MAPK, suppression of NF-κB signaling and Keratin 16 and the cytoprotective effects of MMP-2 and Tie-2.⁸⁰ These effects are particularly relevant in infections where skin integrity is compromised. Lupeol is also known to possess antibiofilm activity which can make bacteria more susceptible to antibiotics and the immune system.⁸¹

On the other hand, friedelin (3) isolates from plants have also shown antibacterial activity against B. subtilis, S. aureus, Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa.^82–84 Friedelin is a pentacyclic triterpenoid just like lupeol, specifically a perhydropicene derivative with an oxo group at position 3 and methyl groups at positions 4, 4a, 6b, 8a, 11, 12b, and 14a. Its antimicrobial activity is thus influenced by its ability to exert anti-inflammatory, antioxidant, and immunomodulatory effects.⁸⁵

Taken together, these reports suggests that the isolated compounds could be responsible for the claimed antibacterial effect of these compounds. Such inhibitory activities may also be related to the interaction of the compounds with the bacterial membrane proteins or lipids leading to bacterial membrane stabilization and disruption, inhibition of membrane-bound enzymes, modulation of immune response and lipid raft disruption. For example, trans-fagaramide being an amide compound with potential amphipathic properties may insert itself into the bacterial membrane. This can disrupt the membrane's lipid bilayer, increasing its permeability and leading to leakage of cellular contents. The disruption of membrane integrity can cause osmotic imbalance, leading to cell death.⁸⁶

The observed differences in ZOI and MIC in the antimicrobial assays could be due to factors such as physicochemical properties of the compounds (solubility, molecular size, stability and lipophilicity), diffusion rate in the agar medium, microbial strain differences and compound interactions (in the case of extracts).⁸⁷ The higher MIC values obtained suggests that higher doses of the plant extracts are needed to effectively treat microbial infections using the plant parts.⁴⁹

Conclusion

This study was undertaken to verify the traditional claims of using A. boonei leaves and I. cairica aerial parts in ethnomedicinal treatment of microbial infections in Uganda. Isolation and characterization of compounds from their DCM/MeOH extracts afforded antibacterial compounds (trans-fagaramide and lupeol from A. boonei, and friedelin from I. cairica). These results lend credence to the use of these species in herbal treatment of bacterial diseases in Uganda. In vivo studies using animal models to evaluate the efficacy and safety of the extracts or isolated compounds from A. boonei and I. cairica could provide stronger evidence of their pharmacological effects, dosage safety, and potential toxicity, complementing the in vitro antibacterial results. Further studies should consider examining the polyphenolic content and antioxidant potential of the extracts and isolated compounds.

Supplemental Material

sj-docx-1-npx-10.1177_1934578X241286425 - Supplemental material for Antibacterial Properties of Phytochemicals Isolated from Leaves of Alstonia boonei and Aerial Parts of Ipomoea cairica

Supplemental material, sj-docx-1-npx-10.1177_1934578X241286425 for Antibacterial Properties of Phytochemicals Isolated from Leaves of Alstonia boonei and Aerial Parts of Ipomoea cairica by Ivan Gumula, Christine Kyarimpa, Sarah Kiwanuka Nanyonga, George Kwesiga, George Busulwa, Boniface Opio, Mathias Heydenreich and Timothy Omara in Natural Product Communications

Footnotes

Acknowledgments

We acknowledge the laboratory support of John Chrysostom Opedun and Fred Mutai during the isolation of compounds and antibacterial assays, respectively.

Data Availability

Data supporting the conclusions of this study are available within this article and its supplementary files.

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

ORCID iD

Ivan Gumula

Supplemental Material

Supplemental material for this article is available online.

References

GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2023;400(10369):2221-2248.

Esposito

Turku

Lehrfield

Shoman

. The impact of human activities on zoonotic infection transmissions. Animals (Basel). 2023;13(10):1646.

Baker

Mahmud

Miller

, et al. Infectious disease in an era of global change. Nat Rev Microbiol. 2022;20(4):193-205.

Elhadi

Khaled

Msherghi

. Infectious diseases as a cause of death among cancer patients: a trend analysis and population-based study of outcome in the United States based on the surveillance, epidemiology, and End results database. Infect Agents Cancer. 2021;16(1):72.

Pashkov

Pak

Pashkov

, et al. The prospects for the use of drugs based on the phenomenon of RNA interference against HIV infection. Vopr Virusol. 2022;67(4):278-289.

Okaiyeto

Oguntibeju

. African herbal medicines: adverse effects and cytotoxic potentials with different therapeutic applications. Int J Environ Res Public Health. 2021;18(11):5988.

Ssenku

Okurut

Namuli

, et al. Medicinal plant use, conservation, and the associated traditional knowledge in rural communities in Eastern Uganda. Trop Med Health. 2022;50(1):39.

Tabuti

JRS

Obakiro

Nabatanzi

, et al. Medicinal plants used for treatment of malaria by indigenous communities of Tororo District, Eastern Uganda. Trop Med Health. 2023;51(1):34.

Omara

. Antimalarial plants used across Kenyan communities. Evid-based Complement Altern Med. 2020;2020:4538602.

10.

Van Wyk

. A family-level floristic inventory and analysis of medicinal plants used in traditional African medicine. J Ethnopharmacol. 2020;249:112351.

11.

Asiimwe

Namukobe

Byamukama

Imalingat

. Ethnobotanical survey of medicinal plant species used by communities around Mabira and Mpanga central forest reserves, Uganda. Trop Med Health. 2021;49(1):52.

12.

Nakaziba

Anyolitho

Amanya

, et al. Traditional medicinal vegetables in Northern Uganda: an ethnobotanical survey. Int J Food Sci. 2021;2021:5588196.

13.

Katumba

Boffa

J-M

Abigaba

Okorio

. Domestication of medicinal tree species in the Victoria lakeshore region. Uganda J Agric Sci. 2004;9:84-88.

14.

Tugume

Kakudidi

Buyinza

, et al. Ethnobotanical survey of medicinal plant species used by communities around mabira central forest reserve, Uganda. J. Ethnobiol. Ethnomed. 2016;12:5.

15.

Iwu

. Pharmacognostical profile of selected medicinal plants. In: Handbook of African Medicinal Plants. CRC Press; 2014, pp.1-506.

16.

Iwuanyanwu

Banjo

Babalola

Olajide

. Neuroprotection by Alstonia boonei De Wild., Anacardium occidentale L., Azadirachta indica A.juss. And Mangifera indica L. J Ethnopharmacol. 2023;310:116390.

17.

Majekodunmi

Adegoke

Odeku

. Formulation of the extract of the stem bark of Alstonia boonei as tablet dosage form. Trop J Pharmaceut Res. 2008;7(2):987-994.

18.

Adotey

Adukpo

Opoku Boahen

Armah

. A review of the ethnobotany and pharmacological importance of Alstonia boonei De Wild (Apocynaceae). ISRN Pharmacol. 2012;2012:587160.

19.

Afolabi

Abejide

. Antiplasmodial activities of Morinda lucida (Benth) and Alstonia boonei (De wild) in mice infected with Plasmodium berghei. Bull Natl Res Cent. 2020;44(1):85.

20.

Marie-Esther

Concilia

Chioma

Chimaobi

Austin

. In vivo antimalarial and cytotoxicity activity of ethanolic stem bark of Petersianthus macrocarpus and leaf of Astonia boonei in experimental mice model. Int J Curr Microbiol Appl Sci. 2013;2(12):354-368.

21.

Onyishi

Nwosu

Eyo

. In vivo studies on the biochemical indices of Plasmodium berghei infected mice treated with Alstonia boonei leaf and root extracts. Afr Health Sci. 2020;20(4):1698-1709.

22.

Atanu

Idih

Nwonuma

Hetta

Alamery

El-Saber Batiha

. Evaluation of antimalarial potential of extracts from Alstonia boonei and Carica papaya in Plasmodium berghei-infected mice. Evid Based Complement Alternat Med. 2021;2021:2599191.

23.

Omoya

Oyebola

. Antiplasmodial activity of stem bark and leaves of Alstonia boonei (De Wild). J Microbiol Experiment. 2019;7(5):241-245.

24.

Akinnawo

Anyasor

Osilesi

. Aqueous fraction of Alstonia boonei de Wild leaves suppressed inflammatory responses in carrageenan and formaldehyde induced arthritic rats. Biomed Pharmacother. 2017;85:95-101.

25.

Olajide

Awe

Makinde

, et al. Studies on the anti-inflammatory, antipyretic and analgesic properties of Alstonia boonei stem bark. J Ethnopharmacol. 2000;71(1-2):179-186.

26.

Opoku

Akoto

. Antimicrobial and phytochemical properties of Alstonia boonei extracts. Org Chem Curr Res. 2015;1(4):137.

27.

Omitola

. Molecular and biological standardisation of Alstonia boonei De Wild. and Alstonia congensis Engl. leaves and stem-barks . PhD Thesis. University of Ibadan; 2021.

28.

Al Qathama

Ezuruike

Mazzari

ALDA

Yonbawi

Chieli

Prieto

. Effects of selected Nigerian medicinal plants on the viability, mobility, and multidrug-resistant mechanisms in liver, colon, and skin cancer cell lines. Front Pharmacol. 2020;11:546439.

29.

Adjouzem

Gilbert

Mbiantcha

, et al. Effects of aqueous and methanolic extracts of stem bark of Alstonia boonei De wild. (Apocynaceae) on dextran sodium sulfate-induced ulcerative colitis in wistar rats. Evid-based Complement Altern Med. 2020;2020:4918453.

30.

Uroko

Okpashi

Bayim

BPR

Onwuekwe

Ucho

Wallace

. Dietary effect of Alstonia Boonei stem bark extract on hematological profiles of Wistar albino rats after inducing oxidative stress with CCl₄. Afr J Biol Sci. 2020;2(4):45-56.

31.

Marini-Bettolo

Nicoletti

Messana

, et al. Research on African medicinal plants-IV1 1 part III: boonein, A new C-9 terpenoid lactone from Alstonia boonei: a possible precursor in the indole alkaloid biogenesis. Tetrahedron. 1983;39(2):323-329.

32.

Olanlokun

Olotu

David

Idowu

Soliman

Olorunsogo

. A novel compound purified from Alstonia boonei inhibits plasmodium falciparum lactate dehydrogenase and plasmepsin II. J Biomol Struct Dyn. 2019;37(8):2193-2200.

33.

Kiganda

. Phytochemical Investigation of Alstonia boonei and Schizozygia coffaeoides for Cytotoxic Principles . Masters Thesis. University of Nairobi, Nairobi; 2018.

34.

Pomilio

Mercader

. Natural acylated anthocyanins and other related flavonoids: Structure elucidation of ipomoea cairica compounds and QSAR studies including multidrug resistance. Stud Nat Prod Chem. 2018;293–322.

35.

Adepiti

Nyamboki

Kibrom

Elujoba

Spiteller

Matasyoh

. Secondary metabolites from the stem bark of Alstonia boonei and the seeds of Picralima nitida with antibacterial activities. Nat Prod Res. Available online: https://doi.org/10.1080/14786419.2024.2349254 (accessed on 8th May 2024)

36.

Chen

Cai

Xiang

Qin

Peng

. Thermal adaptation of photosynthetic physiology of the invasive vine Ipomoea cairica (L.) enhances its advantage over native Paederia scandens (Lour.) Merr. in South China. Tree Physiol. 2023;43(4):575-586.

37.

Kamatenesi-Mugisha

Oryem-Origa

Odyek

Makawiti

. Medicinal plants used in the treatment of fungal and bacterial infections in and around Queen Elizabeth biosphere reserve, western Uganda. Afr J Ecol. 2008;46(s1):90-97.

38.

Gumisiriza

Birungi

Olet

Sesaazi

. Medicinal plant species used by local communities around Queen Elizabeth National Park, Maramagambo Central Forest Reserve and Ihimbo Central Forest Reserve, South western Uganda. J Ethnopharmacol. 2019;239:111926.

39.

Ochwang'i

Kimwele

Oduma

Gathumbi

Mbaria

Kiama

. Medicinal plants used in treatment and management of cancer in Kakamega County, Kenya. J Ethnopharmacol. 2014;15(3):1040-1055.

40.

Ferreira

Amaral

Duarte

, et al. Antinociceptive effect from Ipomoea cairica extract. J Ethnopharmacol. 2006;105(1-2):148-153.

41.

Álvarez

Rodríguez

Vargas

. Bioguided phytochemical study of Ipomoea cairica extracts with larvicidal activity against Aedes aegypti. Molecules. 2022;27(4):1348.

42.

Samuel

Lalrotluanga, Muthukumaran

Gurusubramanian

Senthilkumar

. Larvicidal activity of Ipomoea cairica (L.) sweet and Ageratina adenophora (Spreng.) King & H. Rob. plant extracts against arboviral and filarial vector, Culex quinquefasciatus say (Diptera: culicidae). Experiment Parasitol. 2014;141:112-121.

43.

Rodzay

Zuharah

. The determination of effective concentration of acethonilic Ipomoea cairica leaves extract against laboratory and field strains of Aedes albopictus and Aedes aegypti mosquito larvae. Trop Biomed. 2021;38(3):446-452.

44.

Luo

Wang

Zhang

Kong

. Pentasaccharide resin glycosides from Ipomoea cairica and their cytotoxic activities. Phytochem. 2013;95:421-427.

45.

Pan

Yin

. Two novel resin glycosides isolated from Ipomoea cairica with α-glucosidase inhibitory activity. Chin J Nat Med. 2016;14(3):227-231.

46.

Pan

Yin

, et al. Four new pentasaccharide resin glycosides from Ipomoea cairica with strong α-glucosidase inhibitory activity. Molecules. 2015;20(4):6601-6610.

47.

Omara

Kiprop

Kosgei

. Phytochemicals, polyphenols content, in vitro antioxidant and antibacterial activities of Albizia coriaria Welw ex. Oliver Flowers. Tradit Med Res. 2023;8(2):7.

48.

Byamukama

Barbara

Namukobe

Heydenreich

Kiremire

. Bioactive compounds in the stem bark of Albizia coriaria (Welw. ex Oliver). Int. J. Biol. Chem. Sci. 2015;9(2):1013-1024.

49.

Omara

Kiprop

Kosgei

. Intraspecific variation of phytochemicals, antioxidant, and antibacterial activities of different solvent extracts of Albizia coriaria leaves from some agroecological zones of Uganda. Evid-based Complement Alternat Med. 2021:2021:2335454.

50.

Oloya

Namukobe

Heydenreich

Ssengooba

Schmidt

Byamukama

. Antimycobacterial activity of the extract and isolated compounds from the stem bark of Zanthoxylum leprieurii Guill. and Perr. Nat Prod Comm. 2021;16(8):1-8.

51.

Teclegeorgish

Mokgalaka

Kemboi

, et al. Phytochemicals from Pterocarpus angolensis DC and their cytotoxic activities against breast cancer cells. Plants. 2024;13(2):301.

52.

Kumar

Chandan

Kushwaha

, et al. Discovery of anti-NRLP3 inflammasome, immunomodulatory phytochemicals from the extract of Habenaria intermedia D. Don: an unexplored plant species. ACS Omega. 2023;8(34):31112-31122.

53.

Fotie

Bohle

Leimanis

Georges

Rukunga

Nkengfack

. Lupeol long-chain fatty acid esters with antimalarial activity from Holarrhena floribunda. J Nat Prod. 2006;69(1):62-67.

54.

Cheng

Yang

Lin

Tsai

Chen

. Chemical constituents from the leaves of Zanthoxylum schinifolium. J Chinese Chem Soc. 2002;49(1):125-128.

55.

Goodman

Hoang

Diallo

Malterud

McFadden

Wangensteen

. Anti-plasmodial effects of Zanthoxylum zanthoxyloides. Planta Med. 2019;85(13):1073-1079.

56.

Mbaze

Lado

Wansi

, et al. Oxidative burst inhibitory and cytotoxic amides and lignans from the stem bark of Fagara heitzii (Rutaceae). Phytochem. 2009;70(11-12):1442-1447.

57.

Jain

Bari

. Isolation of lupeol, stigmasterol and campesterol from petroleum ether extract of woody stem of Wrightia tinctoria. Asian J Plant Sci. 2010;9(3):163-167.

58.

Rajic

Kweifio-Okai

Macrides

Sandeman

Chandler

Polya

. Inhibition of serine proteases by anti-inflammatory triterpenoids. Planta Med. 2000;66(1):206-210.

59.

Fabiyi

Atolani

Olatunji

. Identification of some chemical constituents of the leaves of Alstonia boonei and Bridelia ferruginea. Selcuk J Agr Food Sci. 2016;30(1):21-28.

60.

Omara

Kiprop

Kosgei

. Albizia coriaria Welw ex Oliver: a review of its ethnobotany, phytochemistry and ethnopharmacology. Adv Tradit Med. 2023;23:631-646.

61.

Bakare

Abdullahi

Ilyas

Dauda

Erumiseli

Jimoh

. Triterpenoids from the aerial part of Bryophyllum pinnatum (Lam.) oken (crassulaceae). J Pharmaceut Allied Sci. 2021;18(3):3513-3518.

62.

Muhammad

Hassan

Sani

Jimoh

Bakare

Sadam

. Isolation and characterization of lupeol and stigmasterol from methanol root extract of Combretum hypopolinum (diels.) Okafor(Combretaceae). J Pharmaceut Allied Sci. 2021;8(4):87-98.

63.

Thanakijcharoenpath

Theanphong

. Triterpenoids from the stem of Diospyros glandulosa. Thai J Pharm Sci. 2007;31:1-8.

64.

Yin

Kong

. Ether-soluble resin glycosides from the roots of Ipomoea batatas. J Asian Nat Prod Res. 2008;10(3-4):245-252.

65.

El Deeb

Al-Haidari

Mossa

Ateya

. Phytochemical and pharmacological studies of Maytenus forsskaoliana. Saudi Pharm J. 2003;11(4):184-191.

66.

Ferreira

Oliveira

Evangelista

, et al. Biological activities of aerial parts of Ipomoea cairica (Convolvulaceae). Rev Bras Pl Med Botucatu. 2006;8(2):14-18.

67.

Antonisamy

Duraipandiyan

Ignacimuthu

. Anti-inflammatory, analgesic and antipyretic effects of friedelin isolated from Azima tetracantha Lam. in mouse and rat models. J Pharm Pharmacol. 2011;63(8):1070-1077.

68.

Manoharan

Benny

Yang

. Cycloartane type triterpenoids from the rhizomes of Polygonum bistorta. Phytochem. 2005;66(19):2304-2308.

69.

Onishi

Hanaoka

. Studies on the chemical components of Quercus stenophylla Makino. I. Isolation of friedelin from the leaves of Quercus stenophylla Makino. Yakugaku Zasshi. 1968;88(9):1244-1245.

70.

Olanlokun

David

. Antibacterial activity of partitioned methanolic extract of Alstonia boonei (De Wild) against some medically important pathogens. Biosci Biotechnol Res Asia. 2007;4(1):135-139.

71.

Arora

Kumar

Shiba . Phytochemical, antimicrobial and antioxidant activities of methanol extract of leaves and flowers of Ipomoea cairica. Int J Pharm Pharm Sci. 2013;5(1):198-202.

72.

Pethe

Bifani

Jang

, et al. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nature Med. 2013;19(9):1157-1160.

73.

Rosandy

Ishak

SSO

Sabria

Ahmada

WYW

Al Muqarrabund

LMR

. Antibacterial activity of lupeol from the bark of Dehaasia cuneate (Lauraceae). Curr Res Biosci Biotechnol. 2021;2(2):145–148.

74.

Okusa

Stévigny

Névraumont

, et al. Ferulaldehyde and lupeol as direct and indirect antimicrobial compounds from Cordia gilletii (Boraginaceae) root barks. Nat Prod Comm. 2014;9(3):619-622.

75.

Obey

von Wright

Orjala

Kauhanen

Tikkanen-Kaukanen

. Antimicrobial activity of Croton macrostachyus stem bark extracts against several human pathogenic Bacteria. J Pathogens. 2016;2016:1453428.

76.

Akwu

Naidoo

Singh

Thimmegowda

Nundkumar

Lin

. Isolation of lupeol from Grewia lasiocarpa stem bark: antibacterial, antioxidant, and cytotoxicity activities. Biodiversitas. 2020;21(12):5684-5691.

77.

Sudhahar

Ashok

Varalakshmi

Sujatha

. Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage. Mol Cell Biochem. 2008;317(1-2):11-20.

78.

Park

Rehman

Choe

Ahmad

Lee

Kim

. A triterpenoid lupeol as an antioxidant and anti-neuroinflammatory agent: impacts on oxidative stress in Alzheimer’s disease. Nutrients. 2023;15(13):3059.

79.

Beserra

Sérgio Gushiken

Vieira

, et al. From inflammation to cutaneous repair: topical application of lupeol improves skin wound healing in rats by modulating the cytokine levels, NF-κB, Ki-67, growth factor expression, and distribution of collagen fibers. Int. J. Mol. Sci. 2020;21(14):4952.

80.

Beserra

Xue

Maia

GLdA

Leite Rozza

Helena Pellizzon

Jackson

. Lupeol, a pentacyclic triterpene, promotes migration, wound closure, and Contractile effect in vitro: possible involvement of PI3 K/Akt and p38/ERK/MAPK pathways. Molecules. 2018;23(11):2819.

81.

Tamfu

Munvera

Botezatu

AVD

, et al. Synthesis of benzoyl esters of β-amyrin and lupeol and evaluation of their antibiofilm and antidiabetic activities. Results Chem. 2022;4:100322.

82.

Ambarwati

NSS

Elya

Malik

Hanafi

Omar

. Isolation, characterization, and antibacterial assay of friedelin from Garcinia latissima Miq. leaves. J Phy Conf Series. 2019;1402:055078.

83.

Kuete

Nguemeving

Beng

, et al. Antimicrobial activity of the methanolic extracts and compounds from Vismia laurentii De Wild (Guttiferae). J Ethnopharmacol. 2007;109(3):372-379.

84.

Salasa

Velasco

Rojasa

Morales

. Antibacterial activity of the crude extract and constituents of Vismia baccifera var. dealbata (Guttiferae) collected in Venezuela. Nat Prod Comm. 2007;2(2):185-188.

85.

Singh

Shrivastava

Mishra

, et al. Friedelin: structure, biosynthesis, extraction, and its potential health impact. Molecules. 2023;28(23):7760.

86.

Stojowska-Swędrzyńska

Kuczyńska-Wiśnik

Laskowska

. New strategies to kill metabolically-dormant cells directly bypassing the need for active cellular processes. Antibiotics. 2023;12(6):1044.

87.

Bubonja-Šonje

Knežević

Abram

. Challenges to antimicrobial susceptibility testing of plant-derived polyphenolic compounds. Arh Hig Rada Toksikol. 2020;71(4):300-311.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.33 MB